Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study.
Journal Information
Full Title: Can J Gastroenterol Hepatol
Abbreviation: Can J Gastroenterol Hepatol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of Interest The authors declare that they have no conflicts of interest."
"The study was supported by the Shanghai Pujiang Program (17PJD005), the National Natural Science Foundation of China (81670528, 81672009, and 81871640), Scientific Research Fund of Huashan Hospital, Fudan University (2016QD073), and the Shanghai Municipal Health Funds (201840024 to FY)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025